MKNK1 and leukemia: These results confirmed that ribavirin could repress the eIF4E function through down-regulating the phosphorylation of mTOR, MEK/Mnk1/2 signaling pathways, reducing the onco-protein synthesis, and having an anti-leukemic role in Ph+ leukemia cell lines.